I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...

Moderna Inc (NASDAQ:MRNA) shares rallied 13% over a multi-day period following reports of a localized Hantavirus outbreak aboard the cruise vessel MV Hondius.

CIA whistleblower James Erdman III alleges a federal cover-up of COVID-19 origins in Senate testimony, calling for sweeping ...

The 2026 cruise ship outbreak has thrust into global view a pathogen with a 40 percent fatality rate, no approved treatment ...

At least 80 deaths have been reported in Congo's new Ebola disease outbreak, authorities said, as health workers race to ...

Perth biotech Syngenis is using artificial intelligence to slash the time and cost of discovering RNA therapies and ...

A localized outbreak, even a fatal one, is unlikely to spark the multibillion-dollar revenue catalyst that Moderna needs.

The next big one won't come from the hantavirus cruise outbreak, but there are still lessons to take away from it, experts say.

Peter Daszak is a British-born zoologist and disease ecologist best known for his work on emerging zoonotic diseases and for ...

In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer ...

As the Trump administration sought to reassure Americans this week that a potential hantavirus outbreak posed little risk to ...

The work of Peter Aaby and Christine Stabell Benn has long been controversial. Until Robert F. Kennedy Jr. became US health ...